跳至主要内容
临床试验/IRCT20151123025202N3
IRCT20151123025202N3招募中1 期

Study on Effectivness of Topical Furesemaide administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery in patients with chronic rhinosinusitis

Hamedan University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Patients with chronic rhinosinusitis with or without polyposis (primary or recurrent)
  • Ages between 18 and 60 years
  • Normalization of PT, PTT, INR, BT, CT and platelet count

排除标准

  • have Bleeding disorders such as uncontrolled hemophilia
  • Uncontrolled history of thromboembolic events Uncontrolled
  • Receive heparin at 48 hours before surgery
  • ake aspirin within 3 days before surgery
  • Allergies to Furesemaide
  • Liver Cirrhosis
  • Systemic diseases such as hypertension, diabetes, heart failure
  • Patients with sinonasal tumor
  • side effects of Furesemaide
  • acute or chronic renal failure
  • Cardiac stent

研究者

相似试验